Clidet no. 403 (Pty) Ltd and Midas Ltd (47/LM/Jul02) [2002] ZACT 47 (24 July 2002)

Clidet no. 403 (Pty) Ltd and Midas Ltd (47/LM/Jul02) [2002] ZACT 47 (24 July 2002)

The Tribunal found that the merger constitutes a management buy-out, with Midas management and ABSA Bank acquiring Dorbyl's interests in Midas. Neither the management nor ABSA controls any competitor of Midas, and there is no overlap in the product markets of the merging parties. Consequently, the merger does not increase market concentration. The Tribunal agreed with the Competition Commission's recommendation that the merger will not substantially prevent or lessen competition. Furthermore, the merger will not result in retrenchments or raise any other public interest concerns. Accordingly, the merger was approved without conditions.

Citation
[2002] ZACT 47
Parties
Applicant: Clidet No. 403 (Pty) Ltd; Respondent: Midas Limited
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
24 July 2002
Case Number
47/LM/Jul02
Procedural Posture
Large Merger Review / Merger Clearance
Outcome
Merger approved without conditions.
Judges
N. Manoim, D. Lewis, M. Moerane
Legal Topics
Large Merger, Management Buy Out, Public Interest, Market Concentration, Merger Clearance
Competition Law Large Merger Management Buy Out Public Interest Market Concentration Merger Clearance

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Clidet No. 403 (Pty) Ltd

Applicant

Midas Limited

Respondent

Procedural Posture

Large Merger Review / Merger Clearance

Legal Issues

  1. 1 Whether the proposed merger between Clidet No. 403 (Pty) Ltd and Midas Limited will substantially prevent or lessen competition in the relevant markets.
  2. 2 Whether the merger raises any public interest concerns, including retrenchments or other adverse effects.

Ratio Decidendi

The Tribunal found that the merger constitutes a management buy-out, with Midas management and ABSA Bank acquiring Dorbyl's interests in Midas. Neither the management nor ABSA controls any competitor of Midas, and there is no overlap in the product markets of the merging parties. Consequently, the merger does not increase market concentration. The Tribunal agreed with the Competition Commission's recommendation that the merger will not substantially prevent or lessen competition. Furthermore, the merger will not result in retrenchments or raise any other public interest concerns. Accordingly, the merger was approved without conditions.

Court Disposition

Merger approved without conditions.

Orders

  • The merger between Clidet No. 403 (Pty) Ltd and Midas Limited is approved without conditions.
  • A Merger Clearance Certificate is issued.